Showing results (41-50 of 67) with videos related to
Sort By:
Pageof 7
Molecular Cell|April 22, 2020
MYC Controls the Epstein-Barr Virus Lytic SwitchRui Guo, Chang Jiang, Yuchen Zhang, et al.Nature Biotechnology|February 22, 2022
Saturation variant interpretation using CRISPR prime editingSteven Erwood, Teija M I Bily, Jason Lequyer, et al.Blood Advances|October 26, 2020
Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypesHanna Scholze, Regan E Stephenson, Raymond Reynolds, et al.Clinical Journal of Gastroenterology|November 9, 2020
Endoscopic ultrasound-guided diagnosis of Helicobacter pylori-associated gastric Burkitt's lymphoma in an adolescent patient: a rare caseWenly Ruan, Liz Febo-Rodriguez, Chelsea Daignault, et al.JCO Precision Oncology|July 12, 2021
Differential Impact of <i>ALK</i> Mutations in NeuroblastomaTara O'Donohue, Nitya Gulati, Audrey Mauguen, et al.Blood|March 12, 2020
Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapyTanner Dalton, Ekaterina Doubrovina, Dmitry Pankov, et al.Journal of Cell Science|February 12, 2024
Culture substrate stiffness impacts human myoblast contractility-dependent proliferation and nuclear envelope wrinklingJo Nguyen, Lu Wang, Wen Lei, et al.Oncoimmunology|December 15, 2018
Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,<i>in-vitro</i> proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) modelYaya Chu, Sanghoon Lee, Tishi Shah, et al.Blood Advances|March 10, 2023
Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphomaChristopher J Forlenza, Jaclyn Rosenzweig, Audrey Mauguen, et al.Hemasphere|December 13, 2021
A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory LymphomaGraham P Collins, Toby A Eyre, Debora Schmitz-Rohmer, et al.Pageof 7